As Western blot analysis demonstrated that PHF19 knockdown decreased β-catenin expression by increasing SIAH1 expression (Fig. 6a), we hypothesized that SIAH1 might be a downstream effector of PHF19 in GBM cells. The gene discussed is PHF19; the disease is glioblastoma.